Preparation method and application of water-in-oil-in-water emulsion encapsulating marine shell biological calcium

Through the water-in-water emulsion technology of embedding amino acids to chelate calcium and introducing polymers, the solubility of calcium supplements in gastric juice and stability in the intestinal environment is solved, and the effective protection of calcium ions and intestinal tract is achieved. Release improves the absorption rate and stability of calcium nutrition enhancers, and provides a new method for the efficient utilization of marine shell resources.

CN119054927APending Publication Date: 2024-12-03THIRD INSTITUTE OF OCEANOGRAPHY STATE OCEANI C ADMINISTRATION
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411009412.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-26
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Existing calcium supplements are easily affected by gastric acid and intestinal environment during dissolution and absorption, resulting in low absorption rate or great side effects, and the biological activity of marine shell calcium is difficult to protect, affecting its application value.

Method used

Using water-in-water emulsion technology, the chelated marine shell biocalcium of amino acids is embedded in the double emulsion by high-speed homogeneous emulsion, and polymers such as chitosan and hydroxypropyl methylcellulose are introduced to form stable Water-in-oil emulsion enhances its physical stability and controls the release of calcium ions.

Benefits of technology

Improve the physical stability and release characteristics of calcium nutrition enhancers, ensure that calcium ions are mainly released in the intestinal area, reduce the release of gastric juice, improve the absorption rate of calcium and the reduction of side effects, and increase the value of marine waste resources. Utilization provides new ways.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119054927A_ABST
    Figure CN119054927A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method and application of a water-in-oil-in-water emulsion encapsulating marine shell biological calcium, amino acid and shell powder are directly subjected to a water bath chelation reaction, and amino acid chelated marine shell biological calcium is successfully prepared. And embedding the amino acid chelated marine shell biological calcium into the inner water phase of the double emulsion by adopting a high-speed homogeneous emulsification method. The water-in-oil-in-water emulsion prepared by introducing chitosan not only enhances the physical stability, but also realizes the characteristics that the release amount in gastric juice is small, and the water-in-oil-in-water emulsion is mainly released in an intestinal region, so that obvious advantages are shown, and a new way is provided for high-value utilization of marine waste resources.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of nutritional enhancers, and specifically relates to a preparation method of a water-in-oil-in-water emulsion encapsulating marine shell bio-calcium and an application thereof. Background Art

[0002] Calcium is one of the essential trace elements for the human body and is crucial for maintaining peak bone mass and preventing osteoporosis. The activities of every cell in the human body cannot be separated from the participation of calcium. Changes in the concentration of calcium ions in the cytoplasm will trigger a series of physiological reactions, which involve muscle function, hormone regulation, body temperature control, cell division and adhesion, etc. The results of multiple nutrition surveys in my country have shown that calcium is a nutrient that is generally lacking in the national diet. Therefore, calcium supplements have become particularly important.

[0003] Calcium nutritional enhancers have developed to the third generation. The first generation is mainly inorganic acid calcium, including calcium carbonate and calcium hydrogen phosphate, which have a place in the market due to their low cost, wide source and high calcium content. However, the dissolution and absorption of these calcium preparations require the participation of gastric acid, which may cause digestive system diseases such as constipation, so they are mainly suitable for adults. The second generation of calcium preparations are mainly organic acid calcium, such as calcium gluconate and calcium lactate, which have good solubility and less gastrointestinal irritation, but have low calcium content, need to be taken in large quantities, and are not suitable for diabetic patients. The third generation of calcium preparations are mainly organic calcium with biological activity, especially amino acid / peptide chelated calcium, which has a high absorption rate and few side effects.

[0004] As people's understanding of marine resources deepens, shellfish resources have attracted widespread attention. Discarded shells are a rich and economical natural renewable resource, showing good application prospects in the fields of bone repair, health care drugs and drug carriers. Shells account for about 60wt% of the total mass of shellfish, of which the mass fraction of calcium carbonate is as high as 95wt%, making it a high-quality calcium source.

[0005] Marine shell calcium sources and amino acids / peptides can be used to prepare biologically active marine shell bio-chelated calcium through chelation technology. Although researchers have used calcium chloride to prepare chelated calcium, there is still insufficient research on how to overcome the problem that amino acid / peptide chelated calcium is easily hydrolyzed by acid and enzymes. The absorption of free calcium ions is affected by factors in the diet that form insoluble calcium salts (such as phytic acid, oxalate, tannic acid, and alkaline pH in the intestines). Therefore, it is particularly important to protect marine shell bio-calcium from these factors.

[0006] Double emulsion technology has been applied to encapsulate bioactive nutraceuticals and pharmaceutical ingredients. As a complex polydisperse system, water-in-oil-in-water (W1 / O / W2) emulsions show good application potential in masking bad odors and flavors and controlling the release of bioactive ingredients during digestion. The introduction of polymers into double emulsions can improve the stability of the emulsion system. However, many polymers such as sodium alginate, pectin and carrageenan are prone to cross-linking reactions with calcium, which will reduce the physical stability of the emulsion and affect its long-term storage capacity. Summary of the invention

[0007] The purpose of the present invention is to overcome the defects of the prior art and provide a method for preparing a water-in-oil-in-water emulsion encapsulating marine shell biocalcium.

[0008] Another object of the present invention is to provide an application of the water-in-oil-in-water emulsion prepared by the above preparation method.

[0009] The technical solution of the present invention is as follows:

[0010] A method for preparing a water-in-oil-in-water emulsion encapsulating marine shell bio-calcium comprises the following steps:

[0011] (1) placing the cleaned shells in a muffle furnace and calcining at 1000-1100° C.;

[0012] (2) After calcination, grinding to obtain shell powder;

[0013] (3) mixing the amino acid / peptide with the shell powder, adding ultrapure water, adjusting the pH to 7-9, and then chelating at 70-80° C., followed by centrifugation to obtain a supernatant;

[0014] (4) The supernatant is concentrated by heating under reduced pressure, anhydrous ethanol is added, and the mixture is allowed to stand at 3-5° C. for 10-12 h (alcohol precipitation), and then the precipitate is collected by filtration, and the precipitate is freeze-dried to obtain amino acid chelated calcium;

[0015] (5) Take the above-mentioned amino acid chelated calcium, dissolve it in a 0.5-1.5 wt% chitosan (CS) solution as W1, stir until completely dissolved, and then slowly add olive oil containing 7-8 wt% PGPR (polyglycerol ricinoleate) as the oil phase while stirring;

[0016] (6) After stirring evenly, homogenizing at a speed of 12000-12500 rpm to obtain a W1 / O primary emulsion;

[0017] (7) The W1 / O primary emulsion is slowly dripped into a 2-3 wt % hydroxypropyl methylcellulose (HPMC) solution containing 1 wt % Tween 80 as W2 while stirring, the mass ratio of W1 / O to W2 being 1-2:1. After stirring evenly, the mixture is homogenized again to obtain a W1 / O / W2 final emulsion containing chelated calcium.

[0018] In a preferred embodiment of the present invention, in step (4), the volume of anhydrous ethanol added is 8-12 times the volume of the supernatant.

[0019] In a preferred embodiment of the present invention, in step (5), the stirring speed of the dropwise addition of the oil phase is set to 300-400 rpm, and the mass ratio of W1 to the oil phase is 2:3.

[0020] In a preferred embodiment of the present invention, in step (7), the stirring speed is 400-500 rpm, and the homogenizing speed is 9000-10000 rpm.

[0021] In a preferred embodiment of the present invention, the amino acid is lysine.

[0022] A water-in-oil-in-water emulsion encapsulating marine shell biocalcium is prepared by the above-mentioned preparation method.

[0023] The use of the water-in-oil-in-water emulsion in the preparation of a calcium nutritional enhancer.

[0024] A calcium nutrition enhancer, the effective component of which includes the water-in-oil-in-water emulsion.

[0025] In a preferred embodiment of the present invention, the active ingredient is the water-in-oil-in-water emulsion.

[0026] The beneficial effects of the present invention are as follows: the present invention successfully prepares amino acid chelated marine shell bio-calcium by directly subjecting amino acids to a water bath chelation reaction with shell powder, and then uses a high-speed homogenization emulsification method to embed the amino acid chelated marine shell bio-calcium into the inner water phase of a double emulsion; and introduces chitosan to prepare a water-in-oil-in-water emulsion, which not only enhances physical stability but also achieves a small release amount in gastric juice and is mainly released in the intestinal area, thereby showing obvious advantages and providing a new way for the high-value utilization of marine waste resources. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] Figure 1 The figure is a comparison chart of the standing effect of the emulsions prepared in the examples of the present invention and the comparative examples.

[0028] Figure 2 This is a microstructure diagram of the final emulsion containing chelated calcium W1 / O / W2 prepared in Example 1 of the present invention.

[0029] Figure 3 The rheological properties of the emulsions of the embodiments of the present invention and the comparative example W1 / O / W2 are shown in FIG.

[0030] Figure 4 This is a release curve of the final emulsion containing chelated calcium W1 / O / W2 prepared in Example 1 of Example 5 of the present invention in gastrointestinal fluid.

[0031] Figure 5 The transport amount of the final emulsion containing chelated calcium W1 / O / W2 and its encapsulated amino acid chelated calcium in Caco-2 cells prepared in Example 1 of Example 6 of the present invention is shown. DETAILED DESCRIPTION

[0032] The technical solution of the present invention is further illustrated and described below through specific implementation modes in combination with the accompanying drawings.

[0033] Embodiment 1:

[0034] (1) Place the cleaned shells in a muffle furnace and calcine at 1000°C.

[0035] (2) After calcination, grind to obtain 100 mesh shell powder.

[0036] (3) mixing lysine with the shell powder, adding ultrapure water, adjusting the pH to 7, and then chelating in a water bath at 70° C. for 1 h, followed by centrifugation to obtain a supernatant;

[0037] (4) The supernatant is concentrated by heating under reduced pressure, and 10 times the volume of anhydrous ethanol is added, and the mixture is allowed to stand at 4° C. for 10 hours, and then the precipitate is collected by filtration, and the precipitate is freeze-dried to obtain amino acid chelated calcium.

[0038] (5) Weigh 3 g of the above-mentioned amino acid chelated calcium, dissolve it in a 1.5 wt% chitosan solution (W1), stir until completely dissolved, and then slowly add olive oil (oil phase) containing 8 wt% PGPR while stirring. The stirring speed of the oil phase is set to 300 rpm, and the mass ratio of W1 to the oil phase is 2:3 (mass ratio).

[0039] (6) After stirring evenly, use a high-speed disperser to homogenize at a speed of 12000 rpm for 3 min to obtain a W1 / O primary emulsion.

[0040] (7) The W1 / O primary emulsion was slowly dripped into a 2 wt % HPMC solution (W2) containing 1 wt % Tween 80 while stirring, and a cantilever electric stirrer was used to stir at a speed of 400 rpm. The mass ratio of W1 / O to W2 was 2:1. After stirring evenly, a high-speed disperser was used to homogenize at a speed of 9000 rpm for 3 min to obtain a W1 / O / W2 final emulsion containing chelated calcium (such as Figures 1 to 3 shown).

[0041] Embodiment 2:

[0042] Similar to Example 1, but the calcination temperature is 1100°C, the pH is adjusted to 8, the chelation is carried out at 75°C for 1h and then the mixture is allowed to stand for 11h under 4°C alcohol precipitation (the amount of anhydrous ethanol added is the same as that in Example 1), the amount of chelated calcium is 4g, the concentration of the chitosan solution is 1wt%, the oil phase is olive oil containing 7wt% PGPR, the mass ratio of W1 to the oil phase is 2:3, the speed of the high-speed disperser is 12000rpm, the stirring speed of step (7) is 450rpm, the concentration of the HPMC solution containing 1wt% Tween 80 is 2.5wt%, the mass ratio of W1 / O to W2 is 1:1, and the standing effect of the resulting W1 / O / W2 final emulsion containing chelated calcium is as follows: Figure 1 shown.

[0043] Embodiment 3:

[0044] Similar to Example 1, but the pH is adjusted to 9, chelated at 80°C for 1h and then allowed to stand at 4°C for 12h (the amount of anhydrous ethanol added is the same as that in Example 1), the amount of chelated calcium is 5g, the concentration of the chitosan solution is 0.5wt%, the oil phase is olive oil containing 8wt% PGPR, the mass ratio of W1 to the oil phase is 2:3, the speed of the high-speed disperser is 12500rpm, the stirring speed of step (7) is 500rpm, the homogenization speed of step (7) is 10000rpm, the concentration of the HPMC solution containing 1wt% Tween 80 is 3wt%, and the mass ratio of W1 / O to W2 is 2:1.

[0045] Comparative Example 1:

[0046] Similar to Example 3, but the mass ratio of W1 / O to W2 is 3:1. Figure 1 As shown, after standing for 30 days, an oil phase precipitated from the upper layer of the emulsion.

[0047] Comparative Example 2:

[0048] Similar to Example 3, but the mass ratio of W1 / O to W2 is 1:2 or 1:3. Figure 1 As shown, after standing for 30 days, the emulsion separated into layers.

[0049] Comparative Example 3:

[0050] Similar to Example 1, but no HPMC was added to W2. Figure 3 As shown, after standing for 1 day, the emulsion did not delaminate and the viscosity was lower than that in the example, wherein both the storage modulus and the loss modulus were significantly reduced, indicating that the stability of the double emulsion prepared without adding HPMC was reduced.

[0051] Comparative Example 4:

[0052] Similar to Example 1, but no CS was added to W1. Figure 3 As shown, after standing for 1 day, the emulsion was separated and the viscosity was lower than that in the example, wherein both the storage modulus and the loss modulus were significantly reduced, indicating that the stability of the double emulsion prepared without adding CS was significantly reduced.

[0053] Embodiment 4:

[0054] The rheological test of the emulsion of this example was carried out at 25°C using a Haake Mars 60 on steel parallel plates (diameter 40 mm, gap 0.100 mm). The emulsion was deposited on the plate and equilibrated to constant temperature for 5 min. The apparent viscosity (η) was measured by shearing at a rate of 0.1 to 100 s -1 For the frequency tests, a stress value of 1 Pa was applied and all tests were performed in the linear viscoelastic region (strain 1%) with a frequency range of 0.1 to 100 rad s -1 Both the storage modulus (G') and the loss modulus (G") are recorded as a function of frequency to determine whether the emulsion is strongly or weakly flocculated.

[0055] like Figure 3 As shown in Fig. 1, except for Comparative Example 1 (which could not maintain a stable emulsion state), all emulsions showed shear thinning, that is, the viscosity decreased with the increase of the water phase content. In addition, the viscosity of Comparative Examples 3 and 4 was lower than that of the embodiment, indicating that CS and HPMC played an important role in improving the stability of the double emulsion (especially the former), which may be due to the formation of the polymer interface film. At the same time, the storage modulus G' and the loss modulus G", confirmed the above results. Figure 3 As shown in Fig. 2, G' in Example 1 and Example 2 is higher than G", while G">G' in Comparative Example 1 and Comparative Example 2 presents an almost opposite trend, which proves that the emulsions of the examples are stable. It is worth noting that compared with Example 1, the storage modulus and loss modulus of the emulsions of Comparative Example 3 or Comparative Example 4 are significantly reduced ( Figure 3 c), which is consistent with the viscosity result that the polymer can form a strong interfacial film to enhance the elasticity and stability of the emulsion.

[0056] Embodiment 5:

[0057] 5 g of the final emulsion W1 / O / W2 prepared in Example 1 of the present invention was taken and placed in a pre-treated dialysis bag, and the two ends of the dialysis bag were fixed with clips. Artificial small intestinal fluid and artificial gastric fluid were used as release media, and placed in a beaker containing 100 mL of release media to ensure that the dialysis bag was completely immersed. At an ambient temperature of 37° C., it was placed in a constant temperature shaker and shaken at a speed of 100 rpm to simulate the gastrointestinal fluid environment of the human body. Figure 4The release of calcium from free and encapsulated lysine calcium after treatment at different times is shown. Under the action of gastric acid, the coordination bond between Lys and Ca is destroyed, resulting in a rapid release of calcium ions in free Lys-Ca, exceeding 65% within 1 hour and about 68% within 4 hours. However, the calcium ions released by encapsulated Lys-Ca are significantly less, with a release curve of less than 18% within 1 hour and even less than about 20% within 4 hours. This significant difference proves that the W1 / O / W2 emulsion can effectively protect Lys-Ca from damage by gastric acid. When the encapsulated Lys-Ca reaches the small intestinal fluid, Lys-Ca can be continuously released from the emulsion, with a release rate of about 60% in 1 hour and almost complete release at 6 hours.

[0058] Embodiment 6:

[0059] In order to evaluate the calcium transport capacity of the W1 / O / W2 final emulsion prepared in Example 1, the Caco-2 monolayer cell model was used for testing. Figure 5 As shown in a, Lys-Ca in the upper chamber can be absorbed by cells and transferred to the lower chamber. After the Caco-2 monolayer cell model was successfully established after culturing for 21 days, the old culture medium was aspirated and washed twice with HBSS buffer without calcium ions. Then 0.5 mL of HBSS was added to the upper chamber of the insert culture dish and 1.5 mL of HBSS was added to the lower chamber, and incubated in the incubator for 20 minutes. After aspirating HBSS, 0.5 mL of different samples (Lys-Ca, double emulsion containing Lys-Ca) were added to the upper chamber, and 1.5 mL of blank HBSS without calcium ions was added to the lower chamber, and then incubated at 37°C for 2 hours. After incubation, the solution was aspirated from the lower chamber and the calcium content (μg) was measured.

[0060] like Figure 5 As shown in Figure b, compared with the blank control, the group containing 20 mg / mL W1 / O / W2 final emulsion showed a slight effect on cell proliferation, and the proliferation rate of Caco-2 cells reached 109.5%, which ensured that the subsequent evaluation experiment of calcium transport could be carried out smoothly. The calcium transport of free Lys-Ca (aqueous solution) and encapsulated Lys-Ca (20 mg / mL W1 / O / W2 final emulsion) was measured. The results showed that the calcium transport amount of the free lysine calcium group was about 22.06 μg, and the transport rate was as high as 81.71%. Similarly, the calcium transport amount in the encapsulated Lys-Ca group was about 15.98 μg, and the transport rate was also as high as 60%, even in the form of an emulsion.

[0061] The above description is only a preferred embodiment of the present invention, and therefore cannot be used to limit the scope of the present invention. That is, equivalent changes and modifications made according to the patent scope of the present invention and the contents of the specification should still fall within the scope of the present invention.

Claims

1. A method for preparing a water-in-oil-in-water emulsion encapsulating marine shell bio-calcium, characterized in that: The steps include: (1) placing the cleaned shells in a muffle furnace and calcining at 1000-1100° C.; (2) After calcination, grinding to obtain shell powder; (3) mixing the amino acid / peptide with the shell powder, adding ultrapure water, adjusting the pH to 7-9, and then chelating at 70-80° C., followed by centrifugation to obtain a supernatant; (4) The supernatant is concentrated by heating under reduced pressure, anhydrous ethanol is added, and the mixture is allowed to stand at 3-5° C. for 10-12 hours, and then the precipitate is collected by suction filtration, and the precipitate is freeze-dried to obtain amino acid chelated calcium; (5) Take the above amino acid chelated calcium, dissolve it in 0.5-1.5wt% chitosan solution as W1, stir until completely dissolved, and then slowly add olive oil containing 7-8wt% PGPR as the oil phase while stirring; (6) After stirring evenly, homogenizing at a speed of 12000-12500 rpm to obtain a W1 / O primary emulsion; (7) The W1 / O primary emulsion is slowly dripped into a 2-3 wt % hydroxypropyl methylcellulose solution containing 1 wt % Tween 80 as W2 while stirring, the mass ratio of W1 / O to W2 being 1-2:

1. After stirring evenly, the mixture is homogenized again to obtain a W1 / O / W2 final emulsion containing chelated calcium.

2. The preparation method according to claim 1, characterized in that: In the step (4), the volume of anhydrous ethanol added is 8-12 times the volume of the supernatant.

3. The preparation method according to claim 1, characterized in that: In the step (5), the stirring speed of the dropwise addition of the oil phase is set to 300-400 rpm, and the mass ratio of W1 to the oil phase is 2:

3.

4. The preparation method according to claim 1, characterized in that: In the step (7), the stirring speed is 400-500 rpm, and the homogenizing speed is 9000 rpm.

5. The preparation method according to any one of claims 1 to 4, characterized in that: The amino acid is lysine.

6. A water-in-oil-in-water emulsion encapsulating marine shell biocalcium, characterized in that: The invention is prepared by the preparation method described in any one of claims 1 to 5.

7. Use of the water-in-oil-in-water emulsion according to claim 6 in the preparation of a calcium nutritional enhancer.

8. A calcium nutritional enhancer, characterized in that: The effective ingredient thereof comprises the water-in-oil-in-water emulsion according to claim 6.

9. A calcium nutrition enhancer as claimed in claim 8, characterized in that: The active ingredient is the water-in-oil-in-water emulsion.